Distributed Bio Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Distributed Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11514
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Distributed Bio Inc (Distributed Bio) is a provider of bioinformatics services. The company offers support of genomic technologies including NextGen sequencing, antibody informatics and computational bioengineering. It provides modern laboratory information management system to manage sequencing applications such as antibodies, TCRs, viral profiling, and enterotype sequencing. Distributed Bio also offers services in phage display, antibody engineering, synthetic biology, repertoire biomarker analysis and others. The company’s products find applications in Genomic centers and international scientific consortiums and bioengineering, among others. Distributed Bio is headquartered in San Francisco, California, the US.

Distributed Bio Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Distributed Bio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Distributed Bio Enters into Collaboration with H3 Biomedicine 10
Charles River Labs and Distributed Bio Enter into Partnership 11
LakePharma Enters into Agreement with Distributed Bio 12
Licensing Agreements 13
Kadmon Enters into Licensing Agreement with Distributed Bio 13
Pfizer Enters into Licensing Agreement with Distributed Bio for SuperHuman Platform 14
Pandion Therapeutics Enters into Licensing Agreement with Distributed Bio 15
Boehringer Ingelheim Enters into Licensing Agreement with Distributed Bio for SuperHuman Platform 16
Isogenica Enters Into Licensing Agreement With Distributed Bio For Colibra Technology 17
AbCheck Enters Into Licensing Agreement With Distributed Bio For mAB Technology 18
Distributed Bio Inc – Key Competitors 19
Distributed Bio Inc – Key Employees 20
Distributed Bio Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Distributed Bio Inc, Pharmaceuticals & Healthcare, Key Facts 2
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Distributed Bio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Distributed Bio Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Distributed Bio Enters into Collaboration with H3 Biomedicine 10
Charles River Labs and Distributed Bio Enter into Partnership 11
LakePharma Enters into Agreement with Distributed Bio 12
Kadmon Enters into Licensing Agreement with Distributed Bio 13
Pfizer Enters into Licensing Agreement with Distributed Bio for SuperHuman Platform 14
Pandion Therapeutics Enters into Licensing Agreement with Distributed Bio 15
Boehringer Ingelheim Enters into Licensing Agreement with Distributed Bio for SuperHuman Platform 16
Isogenica Enters Into Licensing Agreement With Distributed Bio For Colibra Technology 17
AbCheck Enters Into Licensing Agreement With Distributed Bio For mAB Technology 18
Distributed Bio Inc, Key Competitors 19
Distributed Bio Inc, Key Employees 20

List of Figures
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Distributed Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Distributed Bio Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Exxon Mobil Corporation (XOM)-石油・ガス分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • The Baltimore Life Insurance Company:企業の戦略・SWOT・財務情報
    The Baltimore Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Baltimore Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • OneWorld Health-製薬・医療分野:企業M&A・提携分析
    Summary OneWorld Health (iOWH) is a healthcare service provider that discovers, develops, and delivers safe, effective, and affordable new treatments for diseases disproportionately affecting people in the world. The center treats infectious diseases such as diarrheal diseases, visceral leishmaniasi …
  • Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Myers Industries Inc (MYE):企業の財務・戦略的SWOT分析
    Summary Myers Industries Inc (Myers) is a chemical company that manufactures and distributes plastic and rubber products. The company offers plastic storage containers, rubber tire repair products, custom plastic and rubber products, tire balancers and tire retread products. It also provides materia …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Koninklijke Philips N.V.:企業のM&A・事業提携・投資動向
    Koninklijke Philips N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Koninklijke Philips N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Bellvitge Biomedical Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine. It conducts clinical and basic research for developing treatments and techniques to improve health care. IDIBELL carries its research work in the fields of cancer and human molecular genetics …
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products comprise pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal disorders. Its pipeline pro …
  • Bashneft (BANE)-石油・ガス分野:企業M&A・提携分析
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • Global Voice Group S.A.:企業の戦略的SWOT分析
    Global Voice Group S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Oriental Bank of Commerce:戦略・SWOT・企業財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GREENoneTEc Solarindustrie GmbH:企業の戦略的SWOT分析
    GREENoneTEc Solarindustrie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Datalogic SpA (DAL):企業の財務・戦略的SWOT分析
    Datalogic SpA (DAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆